Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 3
---
less exercise” feature in the Series B            
 Warrants) (“Proposal 1” or, the “Issuance Proposal”);                                                                             |

| 2. | To approve an amendment to our Amended and Restated Certificate of                                                                       
 Incorporation, as amended (the “Charter”) to effect, at the discretion of the Board but prior to the one-year anniversary                
 of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split     
 of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined 
 by the board of directors (the “Board”) of the Company in its discretion and included in a public announcement (“Proposal                
 2” or, the “Reverse Stock Split Proposal”);                                                                                              |

| 3. | To approve the Third Amendment to the Petros Pharmaceuticals, Inc.                                                                   
 Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s   
 Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock (“Proposal 
 3” or, the “Plan Amendment Proposal”);                                                                                               |

| 4. | To approve an amendment to the Charter to increase the number of our                                                                  
 authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of 
 authorized shares of capital stock (“Proposal 4” or, the “Share Increase Proposal”); and                                              |

| 5. | To approve a proposal to adjourn the Special Meeting to a later date                                                                     
 or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes 
 for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (“Proposal 5” or, the “Adjournment      
 Proposal”).                                                                                                                              |

Stockholders are referred
to the Proxy Statement for more detailed information with respect to the matters to be considered at the Special Meeting. After careful
consideration, the Board of Directors recommends a vote “FOR” Proposals 1 - 5.

Who May Vote:

Only stockholders of record
as of the close of business on February